Kirin says that revenue from LC-Plasma, its flagship immune health ingredient, has grown significantly even during spring and summer this year, although these are seasons when consumers tend to take fewer precautions against infectious diseases.
Kirin Holdings’ health science-focused arm Kyowa Hakko says the versatility and stability of its postbiotic ingredient has enabled it to continue to enjoy commercial success beyond the surge of COVID-19.
See the latest developments from health and nutrition brands across Asia-Pacific, including Swisse’s launching its first ‘assessed listed’ complementary medicine in Australia next year, Bayer Consumer Health Division’s approach to infant nutrition innovation,...
Blackmores is set to ramp up advertising to boost brand awareness in China and Indonesia, while also formulating new products with Kirin’s ingredients post the Japanese giants acquisition of the firm.
This round-up looks at the latest financial performance of nutrition and nutraceutical firms, including Swisse’s parent company H&H Group, Kirin, Centrum’s owner Haleon, a2 milk and more.
Kirin’s is targeting Australian acquired Blackmores to achieve a revenue of 100 billion yen (US$687m) and a net operating profit margin of 15 per cent or more by around year 2030, the Japanese-conglomerate said during its latest financial results presentation.
Kirin Holdings and Kellogg’s Japan have co-developed a functional food with “double health claims”, which could also serve as a meal substitute, to meet the rising demand for products that improve intestinal environment and provide immune support at the...
From Kirin announcing its plans to acquire Blackmores to the financial results of Bayer, Suntory, and Danone, here are the most-read stories in May 2023.
Kirin says that functional drinks from its health science domain are the “particular focus” for its beverage business this year after sales of its LC-Plasma immunity range increased by 8.5 per cent to 1.71 million cases in Q1.
This round-up features exclusive analysis on the Kirin and Blackmores deal, Senju-funded research findings, Asahi-owned Dear-Natura’s product development, and more.
Rumours that the Blackmores’ board – and its largest individual shareholder Marcus Blackmore – were open to a takeover have bubbled away for at least 18 months.
Kirin’s is expected to double down on Blackmores’ R&D capabilities and new product development in the wake of its $1.2bn deal, according to exclusive insights from the Japanese giant and industry experts.
See the latest developments from health and nutrition brands across Asia-Pacific, including Avesthagen’s launch of its first preventive health product, Kirin’s first Food with Function Claims (FFC) sports nutrition drink, and Yakult’s reformulation of...
Kirin is launching its first Food with Function Claims (FFC) sports nutrition drink with immune health benefits, as it seeks to tap into active consumers’ demands for multifunctional products.
This round-up features latest research findings in Japan, Suntory’s efforts in alternative packaging materials and recycling infrastructure, Kirin’s potential as a central HMO supplier in Asia, and more.
From a study comparing curcumin and coenzyme Q10 in lowering cholesterol levels, to the opening of Kirin's first human milk oligosaccharides (HMOs) production plant and DSM's temporary reduction of vitamin C production in China, here are the...
See our 10 most-read stories related to Japan’s nutrition industry this year, including Shinya Koso’s insights on the enzyme supplement market, Brand’s Suntory D2C new product launches, Mitsubishi’s nicotinamide mononucleotide (NMN) clinical trial and...
Kirin’s first human milk oligosaccharides (HMOs) production plant has commenced operation and the company anticipates that half of the market will be dominated by China in the future.
This round-up features our latest interviews with Kirin, Morinaga, and Toei Shinyaku during recent business events, including Growth Asia Summit and Vitafoods Asia tradeshow, where the firms outlined their business strategies in South East Asia and more.
Japanese firm Kirin is expanding its presence in South East Asia with its flagship postbiotic ingredient, with collaborations with major dairy companies underway.
This round-up will look at House Wellness’s study on how curcumin extract supplementation could reduce fasting blood glucose and new Foods with Function Claims (FFC) launches from Meiji and Megmilk Snow Brand.
In this round-up, we will shine the spotlight on the Japanese firms that have took home NutraIngredients-Asia Awards 2022, Kao’s supplement launch, government survey on supplement use, and more.
This round-up looks at the popular research surrounding probiotics and its functions, how Kirin is seeing potential in the women’s health sector, and South Korea’s health functional foods production trends.
Kirin has invested in local women’s health brand Wray through its innovation fund aimed at supporting start-ups with innovative and unique technologies.
Kirin has dominated Japan’s Foods with Function Claims (FFC) immune health category in FY21, with it being the only company that has received the authority’s recognition for its immune health ingredient L. lactis strain Plasma – also known as LC-plasma.
This round-up looks at the new product launches in Japan, including Kao’s FFCs for mobility and cognitive health, GABA functional food innovation, and updates from Meiji and Kirin.
The supplementation of a lactic acid bacteria drink has shown to reduce absenteeism in school kids linked to cold and flu within four weeks, said the findings of a Kirin-funded RCT.
Here we feature the latest exclusive trends insights from major dietary supplement firms, including BYHEALTH’s observations in China, immunity developments in Japan from Kirin, plus key NPD areas from Swisse’s parent company H&H.
Kirin is aiming a 20 per cent growth in the number of regular consumers buying functional foods and drinks containing its immune health ingredient LC-plasma – and it is seeking to do so by working with brands that can incorporate the ingredient into various...
Kirin Brewery and Kirin Beverage have announced their respective business strategy for the year ahead, with the former focusing on strengthening its craft beer sales, and the latter on growing its immune care pillar.
Nagasaki University and Kirin Holdings are embarking on a joint clinical research to assess the effect of lactic acid bacteria on relieving symptoms in COVID-19 human subjects.
Kirin said sales of its proprietary functional ingredient Lactococcus lactis strain Plasma and functional foods containing the ingredient has doubled as it detailed plans for its use in both protein bars and powders.
Kirin Holdings and the University of Malaya will work together on a joint research programme to verify the effects of a lactic acid bacteria in other tropical infectious diseases following their latest human clinical study on dengue.
Kirin Holdings, winner of the NutraIngredients-Asia 2021 Immune Support Product of the Year Award, has added 10 new products containing its proprietary Lactococcus lactis strain Plasma (L. lactis strain Plasma) for immune function, bringing the total...
The half-year financial performance of major Japanese health foods companies, including Suntory, Meiji, and Kirin, as well as a new study on umami and stress reduction by Ajinomoto are featured in this Japan industry round-up.
The supplementation of citicoline has shown to significantly improve episodic and overall memory in older adults, according to a 12-week RCT funded by Kyowa Hakko Bio.
Kirin Group is set to roll out four functional foods and dietary supplements containing its proprietary ingredient beta-lactolin (β-lactolin) to support memory health.
Kirin Beverage will focus on no-to-low sugar, low-calorie and products with health benefits across its non-alcohol range after seeing soft drink sales slip by 9% in 2020.
FANCL has launched a new immune supplement that uses technology to protect tablets from premature disintegration during the production and storage process.
Japan-based co-creation platform Trinus has co-developed a new vinegar drink brand called Hoplus with INHOP, a subsidiary of Kirin Holdings, containing matured hop extract.
Kirin subsidiary Kyowa Hakko Bio will manufacture and supply three human milk oligosaccharides (HMOs) at its new Thailand facility by 2022 – both for its parent company and the wider market.
In this round-up, we look at new developments in Japan's health foods and nutraceutical market, including the partnership between Nestle and FANCL in launching sachet veggie smoothies and Kirin's relaunch of its iMUSE brand.
Kirin Holdings and Kirin Beverage are set to relaunch its existing iMUSE brand as a functional food brand in Japan after six of its products received Food with Function Claims (FFC).
